Previous in vitro studies have demonstrated that RASD1 possesses tumor-suppressive potential, such as limiting colony formation, migration, and invasion, in various cancers, including in lung, prostate, breast, gastric cancer and glioma [9,10,11,12,29]. Here, RASD1 is linked to glioma.